• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement.心脏瓣膜置换术后患者口服华法林依从性的分布特征及影响因素
Patient Prefer Adherence. 2018 Sep 3;12:1641-1648. doi: 10.2147/PPA.S172223. eCollection 2018.
2
Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.围手术期机械心脏瓣膜置换术后孕妇的抗凝管理
Arch Gynecol Obstet. 2016 Jan;293(1):69-74. doi: 10.1007/s00404-015-3768-0. Epub 2015 Jun 6.
3
The effect of warfarin knowledge on anticoagulation control among patients with heart valve replacement.华法林知识对心脏瓣膜置换患者抗凝控制的影响。
Int J Clin Pharm. 2020 Jun;42(3):861-870. doi: 10.1007/s11096-020-01043-y. Epub 2020 May 15.
4
Factors Affecting Medication Adherence in Patients with Mechanical Heart Valves Taking Warfarin: The Role of Knowledge on Warfarin, Medication Belief, Depression, and Self-Efficacy.影响服用华法林的机械心脏瓣膜患者药物依从性的因素:华法林知识、药物信念、抑郁和自我效能的作用。
Int J Environ Res Public Health. 2021 May 14;18(10):5214. doi: 10.3390/ijerph18105214.
5
Combining portable coagulometers with the Internet: A new model of warfarin anticoagulation in patients following mechanical heart valve replacement.将便携式凝血仪与互联网相结合:机械心脏瓣膜置换术后患者华法林抗凝治疗的新模式。
Front Surg. 2022 Oct 12;9:1016278. doi: 10.3389/fsurg.2022.1016278. eCollection 2022.
6
Security and cost comparison of INR self-testing and conventional hospital INR testing in patients with mechanical heart valve replacement.机械心脏瓣膜置换患者中INR自我检测与传统医院INR检测的安全性及成本比较
J Cardiothorac Surg. 2015 Jan 16;10:4. doi: 10.1186/s13019-015-0205-1.
7
An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair.英国心胸外科顾问医师瓣膜置换/修复术后抗凝治疗实践的审计
J Heart Valve Dis. 2005 Sep;14(5):576-82.
8
Clinical observation of postoperative warfarin anticoagulation in 300 patients undergoing mitral valve replacement with a carbomedics mechanical valve.300例接受卡波美克斯机械瓣膜二尖瓣置换术患者术后华法林抗凝治疗的临床观察
Heart Surg Forum. 2015 Apr 28;18(2):E063-6. doi: 10.1532/hsf.1241.
9
Increased sensitivity to warfarin after heart valve replacement.心脏瓣膜置换术后对华法林的敏感性增加。
Ann Pharmacother. 2006 Mar;40(3):397-401. doi: 10.1345/aph.1G407. Epub 2006 Feb 28.
10
Pattern of anticoagulation control after heart valve surgery at the Kenyatta National Hospital, Nairobi.内罗毕肯雅塔国家医院心脏瓣膜手术后的抗凝控制模式。
East Afr Med J. 2000 Jul;77(7):354-8. doi: 10.4314/eamj.v77i7.46667.

引用本文的文献

1
Outcome and safety comparison of low-molecular-weight heparin versus unfractionated heparin for bridging anticoagulation in individuals with mechanical heart valves undergoing non-cardiac surgery: A systematic review and meta-analysis.低分子量肝素与普通肝素用于接受非心脏手术的机械心脏瓣膜患者桥接抗凝的疗效与安全性比较:一项系统评价和荟萃分析
Narra J. 2025 Apr;5(1):e1254. doi: 10.52225/narra.v5i1.1254. Epub 2025 Feb 3.
2
Warfarin-Induced Calcification: Potential Prevention and Treatment Strategies.华法林诱导的钙化:潜在的预防和治疗策略。
Rev Cardiovasc Med. 2022 Sep 16;23(9):322. doi: 10.31083/j.rcm2309322. eCollection 2022 Sep.
3
Correlation between Metabolic Parameters and Warfarin Dose in Patients with Heart Valve Replacement of Different Genotypes.不同基因型心脏瓣膜置换患者代谢参数与华法林剂量的相关性
Rev Cardiovasc Med. 2024 Apr 1;25(4):128. doi: 10.31083/j.rcm2504128. eCollection 2024 Apr.
4
Psychological Status and Warfarin Therapy in Patients after Valve Replacement during the COVID-19 Pandemic: A Cross-sectional Study.COVID-19 大流行期间瓣膜置换术后患者的心理状况和华法林治疗:一项横断面研究。
Curr Med Sci. 2024 Aug;44(4):686-691. doi: 10.1007/s11596-024-2889-8. Epub 2024 Jul 6.
5
Addressing the longitudinal components of surgical treatments.解决手术治疗的纵向组成部分问题。
Eur J Epidemiol. 2023 Oct;38(10):1019-1023. doi: 10.1007/s10654-023-01045-w. Epub 2023 Sep 4.
6
Adherence, belief, and knowledge about oral anticoagulants in patients with bioprosthetic heart valve replacement: a cross-sectional study.生物人工心脏瓣膜置换患者口服抗凝剂的依从性、信念和知识:一项横断面研究。
Front Pharmacol. 2023 Jul 12;14:1191006. doi: 10.3389/fphar.2023.1191006. eCollection 2023.
7
Readmissions After Surgical Aortic Valve Replacement: Influence of Prosthesis Type.主动脉瓣置换术后再入院:假体类型的影响。
J Surg Res. 2023 Jul;287:124-133. doi: 10.1016/j.jss.2023.01.007. Epub 2023 Mar 16.
8
Relationship Between Family Caregiver Burden and Medication Adherence in Patients with Mechanical Valve Replacement: A Structural Equation Model.机械瓣膜置换患者家庭照顾者负担与用药依从性的关系:结构方程模型
Patient Prefer Adherence. 2022 Dec 20;16:3371-3382. doi: 10.2147/PPA.S383269. eCollection 2022.
9
Drug-Related Problems in Pulmonary Hypertension with Valvular Heart Disease.瓣膜性心脏病合并肺动脉高压的药物相关问题
Ther Clin Risk Manag. 2022 Dec 2;18:1069-1079. doi: 10.2147/TCRM.S374291. eCollection 2022.
10
Combining portable coagulometers with the Internet: A new model of warfarin anticoagulation in patients following mechanical heart valve replacement.将便携式凝血仪与互联网相结合:机械心脏瓣膜置换术后患者华法林抗凝治疗的新模式。
Front Surg. 2022 Oct 12;9:1016278. doi: 10.3389/fsurg.2022.1016278. eCollection 2022.

本文引用的文献

1
Risk of gastrointestinal bleeding during anticoagulant treatment.抗凝治疗期间胃肠道出血的风险。
Expert Opin Drug Saf. 2017 Jun;16(6):673-685. doi: 10.1080/14740338.2017.1325870. Epub 2017 May 17.
2
Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery.达到治疗性国际标准化比值的时间会增加心脏瓣膜置换术后的住院时间。
Am Heart J. 2017 May;187:70-77. doi: 10.1016/j.ahj.2017.02.011. Epub 2017 Feb 16.
3
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017年美国心脏协会/美国心脏病学会对2014年《美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南》的重点更新:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2017 Jun 20;135(25):e1159-e1195. doi: 10.1161/CIR.0000000000000503. Epub 2017 Mar 15.
4
Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants.服用华法林个体中严重肾功能不全的发生率及其对非维生素K口服抗凝剂的影响。
Am Heart J. 2017 Feb;184:150-155. doi: 10.1016/j.ahj.2016.08.017. Epub 2016 Nov 4.
5
Crosstalk between Vitamins A, B12, D, K, C, and E Status and Arterial Stiffness.维生素A、B12、D、K、C和E状态与动脉僵硬度之间的相互作用
Dis Markers. 2017;2017:8784971. doi: 10.1155/2017/8784971. Epub 2017 Jan 12.
6
Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy.草药与华法林联合使用的机制及相互作用综述
Biomed Pharmacother. 2016 Oct;83:14-21. doi: 10.1016/j.biopha.2016.06.012. Epub 2016 Jun 17.
7
Warfarin Pharmacogenetics: New Life for an Old Drug.华法林药物遗传学:一种老药的新生命
Acta Cardiol Sin. 2013 May;29(3):235-42.
8
Curative effect of mechanical heart valve replacement and anticoagulant therapy after surgery.机械心脏瓣膜置换术后的疗效及术后抗凝治疗
J Biol Regul Homeost Agents. 2016 Jan-Mar;30(1):141-6.
9
The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety.抗凝剂在肥胖患者静脉血栓栓塞治疗和预防中的应用:安全性问题
Expert Opin Drug Saf. 2016 Jan;15(1):65-74. doi: 10.1517/14740338.2016.1120718. Epub 2015 Dec 5.
10
Clinical observation of postoperative warfarin anticoagulation in 300 patients undergoing mitral valve replacement with a carbomedics mechanical valve.300例接受卡波美克斯机械瓣膜二尖瓣置换术患者术后华法林抗凝治疗的临床观察
Heart Surg Forum. 2015 Apr 28;18(2):E063-6. doi: 10.1532/hsf.1241.

心脏瓣膜置换术后患者口服华法林依从性的分布特征及影响因素

Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement.

作者信息

Wang Xiaowu, Xu Bo, Liang Hongliang, Jiang Shuyun, Tan Hongmei, Wang Xinrong, Wang Xia, Yu Shiqiang, Liu Jincheng

机构信息

Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi, People's Republic of China,

Department of Health Statistics, Faculty of Preventive Medicine, Fourth Military Medical University, Xi'an 710032, Shaanxi, People's Republic of China.

出版信息

Patient Prefer Adherence. 2018 Sep 3;12:1641-1648. doi: 10.2147/PPA.S172223. eCollection 2018.

DOI:10.2147/PPA.S172223
PMID:30214166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6126512/
Abstract

PURPOSE

Oral warfarin anticoagulation is a long-term treatment that is required after heart valve replacement. This treatment can prevent serious complications, such as embolism, thereby increasing patients' postoperative survival rates and quality of life. Patients treated with artificial mechanical heart valve replacement were followed up over the phone at different times after the procedure, which is an effective method for preventing accidents related to postoperative oral warfarin anticoagulation. Our goal was to determine a method for providing theoretical guidance to patients on oral warfarin anticoagulation following heart valve replacement.

PATIENTS AND METHODS

The participants of this study were patients who received artificial mechanical heart valve replacements and were followed up for 2 years after the procedure. Patient adherence to medical advice was calculated, and the distribution characteristics of adherence to prescribed timing, prescribed dose, and regular clinical follow-up among patients of both sexes and of different ages, regions, and educational levels attained were compared.

RESULTS

Univariate and multifactorial logistic regression analyses were used to evaluate the factors influencing adherence. Our analyses showed that adherence to oral warfarin anticoagulation in patients after heart valve replacement is influenced by sex, age, residential location, and educational attainment. The medication habits of patients can be evaluated accordingly via phone follow-up. As such, dose adjustment recommendations can be provided, significantly increasing the adherence to oral warfarin anticoagulation in patients after heart valve replacement.

CONCLUSION

Adherence to oral warfarin anticoagulation among patients after heart valve replacement is affected by sex, age, type of residence, and educational level, as well as adherence to clinical follow-up over the phone. The follow-up sessions help establish good doctor-patient communication, which is critical for timely medication guidance, thus shortening medication administration delays and decreasing the overall length of therapy.

摘要

目的

口服华法林抗凝是心脏瓣膜置换术后所需的长期治疗。这种治疗可预防严重并发症,如栓塞,从而提高患者术后生存率和生活质量。对接受人工机械心脏瓣膜置换术的患者在术后不同时间进行电话随访,这是预防术后口服华法林抗凝相关事故的有效方法。我们的目标是确定一种为心脏瓣膜置换术后口服华法林抗凝的患者提供理论指导的方法。

患者与方法

本研究的参与者为接受人工机械心脏瓣膜置换术且术后随访2年的患者。计算患者的医嘱依从性,并比较不同性别、年龄、地区和教育水平患者在规定时间、规定剂量和定期临床随访方面的依从性分布特征。

结果

采用单因素和多因素逻辑回归分析评估影响依从性的因素。我们的分析表明,心脏瓣膜置换术后患者口服华法林抗凝的依从性受性别、年龄、居住地点和教育程度影响。可通过电话随访相应评估患者的用药习惯。因此,可提供剂量调整建议,显著提高心脏瓣膜置换术后患者口服华法林抗凝的依从性。

结论

心脏瓣膜置换术后患者口服华法林抗凝的依从性受性别、年龄、居住类型、教育水平以及电话临床随访依从性的影响。随访有助于建立良好的医患沟通,这对于及时的用药指导至关重要,从而缩短用药延迟并减少总体治疗时长。